Abbott Laboratories

Showing 7 posts of 7 posts found.

mosquito

Abbott’s Zika virus test given FDA authorisation

February 7, 2017
Manufacturing and Production, Research and Development Abbott Laboratories, Zika virus

The threat of the Zika virus, though it may have disappeared from the headlines, is still very much present. Any …

shutterstock_92671375

Indian govt set to ban 1,200 fixed-dose combination drugs, reports

March 18, 2016
Business Services, Medical Communications, Sales and Marketing Abbott Laboratories, Pfizer, cough drug, pharma

Indian regulators are set to ban an additional 1,200 fixed-dose combinations, sent for probe by Drug Controller General of India …

UPDATE: Pfizer gets interim stay on cough syrup ban

March 15, 2016
Manufacturing and Production, Research and Development Abbott Laboratories, Corex, Pfizer, Pfizer India

Shares in Pfizer India continued to tumble for a second day even as an Indian court granted the company a …

st_judes_ensite_precision_mapping_module

Abbott to table $25bn bid for medical device maker St Jude?

August 27, 2015
Manufacturing and Production, Sales and Marketing Abbott Laboratories, mergers and acquisitions, st jude medical

Abbott Laboratories is said to be preparing a $25 billion takeover bid for medical device maker St Jude Medical.  Illinois-based Abbott …

Abbott

Abbott to split into two separate companies

October 20, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Abbott Laboratories

Abbott’s management has decided to split the company into two separate entities in order to give shareholders a ‘distinct investment …

Abbott's Humira (adalimumab)

Abbott wins $1.7bn Humira case

February 24, 2011
Sales and Marketing Abbott, Abbott Laboratories, Centocor, Johnson and Johnson, Remicade, Simponi, TNF, golimumab, infliximab, rheumatoid arthritis

Abbott has been saved from paying Johnson & Johnson $1.7 billion after a US appeals court quashed a patent dispute …

Abbott hep C drug ABT-450/r impresses in mid-stage trial

November 2, 2010
Research and Development ABT-450/r, Abbott, Abbott Laboratories, American Liver Disease congress, Enanta Pharmaceuticals, Norvir, hepatitis C

Mid-stage trial results of Abbott Laboratories’ oral hepatitis C drug ABT-450/r have impressed at the American Liver Disease congress. The …

Latest content